7-吲哚啉磺酰胺 | 111048-65-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 中文名称: 7-吲哚啉磺酰胺
• 英文名称: 7-sulfonamide indoline
• 英文别名: indoline-7-sulfonamide；2,3-dihydro-1H-indole-7-sulfonamide
• CAS: 111048-65-8
• 化学式: C₈H₁₀N₂O₂S
• mdl: MFCD18809192
• 分子量: 198.246
• InChiKey: HLLIZWSHMLSVLJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.5
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  80.6
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  7-吲哚啉磺酰胺 在 N-氯代丁二酰亚胺 、 3 A molecular sieve 、 camphor-10-sulfonic acid 作用下， 以 乙腈 为溶剂， 反应 1.0h， 生成 7-Chloro-3-methyl-1,2,3,4-tetrahydro-5-thia-2a,4-diaza-acenaphthylene 5,5-dioxide
  参考文献：
  名称：

  5′-Alkyl-benzothiadiazides: A New Subgroup of AMPA Receptor Modulators with Improved Affinity

  摘要：

  AMPA receptors form a major subdivision of the glutamate receptor family that mediates excitatory synaptic transmission in the brain, Currents through AMPA receptors can be up- or down-regulated by compounds that allosterically modulate receptor kinetics through binding sites distinct from that for glutamate. One of those modulators is the benzothiadiazide IDRA-21 which has been reported to enhance synaptic transmission and be effective in behavioral tests, but typically requires threshold concentrations of at least 100 muM to be active in vitro. In this study, new benzothiadiazides were developed with IDRA-21 as lead compound and examined for their potency in modulating AMPA receptor kinetics. A significant increase in drug affinity was obtained by alkyl substitution at the 5'-position of IDRA-21; substitutions at other positions of the benzothiadiazide core generally did not yield a further gain in affinity and in some cases abolished drug binding. The 5'-ethyl derivative exhibited an EC50 value in the order of 22 muM which represents about a 30-fold gain in affinity over that of IDRA-21. The EC50 value is comparable to that of cyclothiazide, the most potent benzothiadiazide drug, but the effects on AMPA receptors differed substantially between these two compounds in that the 5'-ethyl derivative of IDRA-21 greatly increased the binding affinity for receptor agonists whereas cyclothiazide is known to reduce agonist binding. The structure-activity relationships reported here thus offer to provide new insights how receptor kinetics is linked to particular aspects of receptor-drug interactions. (C) 2002 Published by Elsevier Science Ltd.

  DOI：

  10.1016/s0968-0896(01)00405-9
• 作为产物：
  描述：

  2,3,5,6-tetrahydropyrrolo<1,2,3-de>-1,2,4-benzothiadiazin-3-one 1,1-dioxide 在 硫酸 作用下， 以 水 为溶剂， 反应 2.0h， 生成 7-吲哚啉磺酰胺
  参考文献：
  名称：

  [EN] INDOLINE AND TETRAHYDROQUINOLINE SULFONYL INHIBITORS OF DIMETALLOENZYMES AND USE OF THE SAME
  [FR] INHIBITEURS DE TYPE INDOLINE ET TÉTRAHYDROQUINOLINE SULFONYLE DES DIMÉTALLO-ENZYMES ET LEUR UTILISATION

  摘要：

  揭示了可以抑制DapE和/或细菌金属β-内酰胺酶（“MBLs”）如NDM-1的吲哚啉和四氢喹啉磺酰化合物。还公开了使用此处披露的化合物治疗患有细菌感染的个体的方法。

  公开号：

  WO2017011408A1

文献信息

• [EN] INDOLINE AND TETRAHYDROQUINOLINE SULFONYL INHIBITORS OF DIMETALLOENZYMES AND USE OF THE SAME<br/>[FR] INHIBITEURS DE TYPE INDOLINE ET TÉTRAHYDROQUINOLINE SULFONYLE DES DIMÉTALLO-ENZYMES ET LEUR UTILISATION
  申请人：UNIV LOYOLA CHICAGO

  公开号：WO2017011408A1

  公开（公告）日：2017-01-19

  Indoline and tetrahydroquinoline sulfonyl compounds that can inhibit DapE and/or bacterial metallo-β-lactamases ("MBLs"), such as NDM-1 are disclosed. Also disclosed are methods of treating an individual suffering from a bacterial infection using the compounds disclosed herein.

  揭示了可以抑制DapE和/或细菌金属β-内酰胺酶（“MBLs”）如NDM-1的吲哚啉和四氢喹啉磺酰化合物。还公开了使用此处披露的化合物治疗患有细菌感染的个体的方法。
• [EN] INDOLINE SULFONAMIDE INHIBITORS OF DAPE AND NDM-1 AND USE OF THE SAME<br/>[FR] INHIBITEURS INDOLINE-SULFONAMIDE DE DAPE ET NDM-1 ET UTILISATION DE CEUX-CI
  申请人：UNIV LOYOLA CHICAGO

  公开号：WO2016025637A1

  公开（公告）日：2016-02-18

  Indoline sulfonamide compounds that can inhibit DapE and/or bacterial metallo-β- lactamases (MBLs), such as NDM-1, are disclosed. Also disclosed are methods of treating an individual suffering from a bacterial infection using the indoline sulfonamide compounds disclosed herein.

  揭示了可以抑制DapE和/或细菌金属β-内酰胺酶（MBLs），如NDM-1的吲哚磺胺类化合物。还揭示了使用这些吲哚磺胺类化合物治疗患有细菌感染的个体的方法。
• Herbicidal sulfonamides
  申请人：E. I. Du Pont de Nemours and Comany

  公开号：US04683000A1

  公开（公告）日：1987-07-28

  Novel N-(heterocyclicaminocarbonyl)arylsulfonamides such as 2,3-dihydro-N-[(4-methoxy-6-methyl-1,3,5-triazin-2-yl)aminocarbonyl]-1H-in dole-7-sulfonamide are useful as pre-emergence and post-emergence herbicides and for the regulation of plant growth.

  新型N-(杂环氨基甲酰)芳基磺酰胺，例如2,3-二氢-N-[(4-甲氧基-6-甲基-1,3,5-三嗪-2-基)氨基甲酰]-1H-吲哚-7-磺酰胺，可用作前期和后期除草剂，并用于植物生长的调节。
• INDOLINE SCAFFOLD SHP-2 INHIBITORS AND CANCER TREATMENT METHOD
  申请人：Wu Jie

  公开号：US20110190315A1

  公开（公告）日：2011-08-04

  The subject invention concerns methods and compounds for inhibiting Shp2. In one embodiment, a compound of the invention has a chemical structure as shown in formula I or II: wherein X, Y, and Z are independently N or S; R 1 is cycloalkyl, heterocycloalkyl, aryl, or heteroaryl, any of which can be optionally substituted with one or more of halogen; alkyl; heteroalkyl; —COOH; —C(R 3 ) 3 , wherein R 3 can independently be any of —H or halogen; or —OR 4 , wherein R 4 can be any of H, alkyl, or heteroalkyl; R 2 is alkyl, alkylcarbonyl, heteroalkylcarbonyl, aryl, arylcarbonyl, heterocycloalkylcarbonyl, cycloalkylcarbonyl, or —C(O)NR 6 R 7 , any of which can be optionally substituted with one or more of halogen; alkyl; heteroalkyl; carbonyl; —OR 4 , wherein R 4 can be —H, alkyl, or heteroalkyl; —OH; —C(R 3 ) 3 , wherein R 3 can independently be any of —H or halogen; aryl, which can be substituted with one or more of halogen or —OR 4 ; heterocycloalkyl; or —C(O)OR 5 , wherein R 5 can be —H or alkyl; R 6 and R 7 are independently —H, alkyl, heteroalkyl, aryl, or heteroaryl; and R′ is H or alkyl; or a pharmaceutically acceptable salt or hydrate thereof.

  本发明涉及用于抑制Shp2的方法和化合物。在一种实施例中，本发明的化合物具有如公式I或II所示的化学结构：其中X，Y和Z分别是N或S；R1是环烷基，杂环烷基，芳基或杂芳基，其中任何一个可以选择性地被一个或多个卤素；烷基；杂烷基；-COOH；-C（R3）3，其中R3可以独立地是-H或卤素；或-OR4，其中R4可以是H，烷基或杂烷基；R2是烷基，烷基羰基，杂烷基羰基，芳基，芳基羰基，杂环烷基羰基，环烷基羰基或-C（O）NR6R7，其中任何一个可以选择性地被一个或多个卤素；烷基；杂烷基；羰基；-OR4，其中R4可以是-H，烷基或杂烷基；-OH；-C（R3）3，其中R3可以独立地是-H或卤素；芳基，可以被一个或多个卤素或-OR4取代；杂环烷基；或-C（O）OR5，其中R5可以是-H或烷基；R6和R7独立地是-H，烷基，杂烷基，芳基或杂芳基；R'是H或烷基；或其药学上可接受的盐或水合物。
• PETERSEN, W. CHRISTIAN
  作者：PETERSEN, W. CHRISTIAN

  DOI：——

  日期：——